CompletedNCT00176449
Bupropion with education to support smoking cessation in schizophrenia
About this title
Read the official source — NCT00176449Medication studyAges 18–64United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- CatonsvilleSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 52
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT00176449
- Official title
Show the full official title
A Comparison of Bupropion SR and Placebo for Smoking Cessation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Catonsville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Bupropion SR and Placebo Oral Tablet.
Who was this study for?
Listed age limits: 18 years to 64 years.
